News

Mie Wolff Kristensen Since the introduction of combination immunotherapy and TKIs, treatment outcomes for mRCC patients have improved markedly with a subset of patients achieving durable or complete responses. Despite these results, a large group of patients do not respond to treatment, and therefore, selecting the right treatment for the right patient is crucial. Treatment […]

By Mads Hvid Poulsen, PhDConsultant, Head of Research, Associate ProfessorDepartment for Urology, Esbjerg and Grindsted Hospital, University Hospital of Southern DenmarkDepartment of Regional Health Research, University of Southern Denmark Prostate cancer remains the most frequently diagnosed malignancy in men across Europe, and early detection through screening has the potential to improve survival outcomes. However, the […]